These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8467838)

  • 1. Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation.
    Jinnai K; Kono N; Yamamoto Y; Kanda F; Ohno S; Tsutsumi M; Yamada Y; Kawachi M; Tarui S; Fujita T
    Eur Neurol; 1993; 33(3):204-7. PubMed ID: 8467838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
    N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can hyperuricemia predict glycogen storage disease (McArdle's disease) in rheumatology practice? (Myogenic hyperuricemia).
    Üsküdar Cansu D; Erdoğan B; Korkmaz C
    Clin Rheumatol; 2019 Oct; 38(10):2941-2948. PubMed ID: 31044384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [McArdle's disease].
    Lavrnić DV; Svetković D; Apostolski S; Rakocević-Stojanović V; Trikić R
    Srp Arh Celok Lek; 1992; 120(7-8):255-8. PubMed ID: 1306014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. McArdle's disease with late-onset symptoms: case report and review of the literature.
    Felice KJ; Schneebaum AB; Jones HR
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.
    Hara N; Mineo I; Kono N; Kiyokawa H; Kawachi M; Yamada Y; Nakajima H; Shimizu T; Kuwajima M; Wang YL
    Adv Exp Med Biol; 1989; 253A():381-6. PubMed ID: 2624217
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical features, diagnosis and treatment of McArdle's glycogenosis].
    Lobzin VS; Saĭkova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):342-5. PubMed ID: 6586038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic power of the non-ischaemic forearm exercise test in detecting glycogenosis type V.
    Hogrel JY; van den Bogaart F; Ledoux I; Ollivier G; Petit F; Koujah N; Béhin A; Stojkovic T; Eymard B; Voermans N; Laforêt P
    Eur J Neurol; 2015 Jun; 22(6):933-40. PubMed ID: 25740218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [McArdle's disease. Apropos of a case].
    Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
    Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. McArdle's disease and gout.
    Puig JG; de Miguel E; Mateos FA; Miranda E; Romera NM; Espinosa A; Gijón J
    Muscle Nerve; 1992 Jul; 15(7):822-8. PubMed ID: 1501625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late diagnosis of a McArdle disease's case (type V glycogenosis)].
    Flavier S; Rolland MO; Eude M; Fédou C; Brun JF; Maire I; Mercier J; Raynaud E
    Ann Biol Clin (Paris); 2007; 65(5):550-4. PubMed ID: 17913675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogenosis 5 or McArdle's disease: case for diagnosis.
    Mil Med; 1983 Jan; 148(1):64, 69, 73. PubMed ID: 6402732
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased plasma uric acid after exercise in muscle phosphofructokinase deficiency.
    Kono N; Mineo I; Shimizu T; Hara N; Yamada Y; Nonaka K; Tarui S
    Neurology; 1986 Jan; 36(1):106-8. PubMed ID: 2934643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [McArdle's disease: a case report].
    Levy JA; Gagioti SM; Cavalieri MJ; Pereira JR
    Arq Neuropsiquiatr; 1980 Dec; 38(4):411-4. PubMed ID: 6937160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Massive rhabdomyolysis revealing a McArdle disease].
    Loupy A; Pouchot J; Hertig A; Bonnard G; Bouvard E; Rondeau E
    Rev Med Interne; 2007 Jul; 28(7):501-3. PubMed ID: 17383055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mcardle's disease. A case report.
    Dirik E; Taşkin F; Eroğlu Y; Büyükgebiz B; Selamzade M; Cevik NT
    Turk J Pediatr; 1996; 38(3):355-9. PubMed ID: 8827906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [McArdle's disease without typical symptoms].
    Watanabe M; Matsubara E; Amari M; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1247-51. PubMed ID: 2085931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.